PartsTable
Technical Data Sheet
Download PDF

NDC00641-6057-25 — MIDAZOLAM HYDROCHLORIDE INJECTIO

✓ Government record, cited
— · COMPONENT
PRODUCT OVERVIEW

NDC00641-6057-25: MIDAZOLAM HYDROCHLORIDE INJECTIO.

MIDAZOLAM HYDROCHLORIDE INJECTIO. Key specifications include administration: INTRAVENOUS AND INTRAMUSCULAR, features_provided: STERILE, primary_container_type: VIAL, pharmaceutical_vehicle_type: AQUEOUS, total_primary_container_quantity: 25, primary_container_content_quantity: 2.0 MILLILITERS. This part is cataloged in the U.S.

Government catalog under NSN 6505-01-660-3866, indicating validated use in U.S. government and defense logistics supply chains. Available through authorized enterprise resellers and TPM (Third Party Maintenance) channels.

Verify compatibility with your specific system configuration before ordering.

WHERE IT FITS
NDC00641-6057-25
NSN: 6505-01-660-3866
FSC: 6505 — Drugs and Biologicals
CAGE: 32655 — HIKMA PHARMACEUTICALS USA INC. (USA)
SPECIFICATIONS
administrationINTRAVENOUS AND INTRAMUSCULAR
features_providedSTERILE
primary_container_typeVIAL
pharmaceutical_vehicle_typeAQUEOUS
total_primary_container_quantity25
primary_container_content_quantity2.0 MILLILITERS
controlled_substance_classificationSCHEDULE IV
active_medicament_medicinal_strength1.0 MILLIGRAMS MIDAZOLAM ACTIVE INGREDIENT
part_name_assigned_by_controlling_agencyVERSED (MIDAZOLAM HCL) 2 MG/ 2 ML INJECTION, 25 VIALS PER PACKAGE
NSN6505-01-660-3866
COMPONENT DIAGRAM
COMPONENT MAIN IC EDGE CONNECTOR No detailed specs available MIDAZOLAM HYDROCHLORIDE INJECTIO TITLE COMPONENT PN NDC00641-6057-25 MFR MIDAZOLAM HYDROCHLORID
KEY FEATURES
•
CONTROLLED SUBSTANCE CLASSIFICATION: SCHEDULE IV
•
ADMINISTRATION: INTRAVENOUS AND INTRAMUSCULAR
•
PRIMARY CONTAINER CONTENT QUANTITY: 2.0 MILLILITERS
•
FEATURES PROVIDED: STERILE
•
PRIMARY CONTAINER TYPE: VIAL
•
PHARMACEUTICAL VEHICLE TYPE: AQUEOUS
TECHNICAL CHARACTERISTICS
CONTROLLED SUBSTANCE CLASSIFICATIONSCHEDULE IV
ADMINISTRATIONINTRAVENOUS AND INTRAMUSCULAR
PRIMARY CONTAINER CONTENT QUANTITY2.0 MILLILITERS
FEATURES PROVIDEDSTERILE
PRIMARY CONTAINER TYPEVIAL
SPECIAL FEATURESEACH ML CONTAINS 1 MG OF MIDAZOLAM IN STERILE WATER FOR INTRAVENOUS OR INTRAMUSCULAR INJECTION; CONTAINS BENZYL ALCOHOL EDETATE DISODIUM AS A PRESERVATIVE; SCHEDULE IV CONTROLLED SUBSTANCE; CONCENTRATION: 1 MG PER ML; VIAL SIZE/FILL VOLUME: 2 ML; PACKAGE QUANTITY: 25 VIALS; STORE AT 20 TO 25 C (68 TO 77 F)
PART NAME ASSIGNED BY CONTROLLING AGENCYVERSED (MIDAZOLAM HCL) 2 MG/ 2 ML INJECTION, 25 VIALS PER PACKAGE
PHARMACEUTICAL VEHICLE TYPEAQUEOUS
ACTIVE MEDICAMENT MEDICINAL STRENGTH1.0 MILLIGRAMS MIDAZOLAM ACTIVE INGREDIENT
TOTAL PRIMARY CONTAINER QUANTITY25
SUBSTITUTES & CROSS-REFERENCES 2
1445405Reference document
Same NSN cross-reference
Reference document — Secondary reference
6505NCM163285Reference document
Same NSN cross-reference
Reference document — Secondary reference
LIFECYCLE
NSN statusActive· U.S. Government catalog
Shelf-life managedAcquisition advice: Terminal item — stock exhausted; no further procurementNo demilitarization required
Ready to buy NDC00641-6057-25?
Compare prices from verified sellers on eBay
Buy on eBay →
As an eBay Partner, PartsTable may earn a commission. Your price is not affected.
FREQUENTLY ASKED QUESTIONS
What is NDC00641-6057-25?
NDC00641-6057-25 is a MIDAZOLAM HYDROCHLORIDE INJECTIO.
What parts can replace NDC00641-6057-25?
There are 2 known substitutes for NDC00641-6057-25: 1445405, 6505NCM163285. Substitute compatibility should be verified for your specific system.
What is the NSN for NDC00641-6057-25?
NDC00641-6057-25 is cataloged in the U.S. Government catalog under NSN 6505-01-660-3866. This indicates validated use in U.S. government and defense supply chains.
Community Feedback
Leave a Comment
Comments are reviewed before appearing. You will receive an email to verify before your comment appears.

Request a Quote — NDC00641-6057-25